# Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma

> **NCT06016400** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 412 (estimated)

## Conditions studied

- Oral Squamous Cell Carcinoma
- Oral Mucositis

## Interventions

- **DRUG:** Alfacalcidol Oral Solution
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06016400
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-14
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-04-30
- **Target enrollment:** 412 (ESTIMATED)
- **Last updated:** 2023-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06016400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06016400, "Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT06016400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*